Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus.

Authors :: Wong, Karen K.
Davey Jr., Richard T.
Hewlett, Angela L.
Kraft, Colleen S.
Mehta, Aneesh K.
Mulligan, Mark J.
Beck, Allison
Dorman, William
Kratochvil, Christopher J.
Lilin Lai
Palmore, Tara N.
Rogers, Susan
Smith, Philip W.
Suffredini, Anthony F.
Wolcott, Mark
Ströher, Ute
Uyeki, Timothy M.
Source :: Clinical Infectious Diseases. 8/1/2016, Vol. 63 Issue 3, p376-379. 4p.
Publication Year :: 2016
Abstract: From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposure prophylaxis; none developed Ebola virus disease. [ABSTRACT FROM AUTHOR]

Full Text Access

Tools